Ankur Drugs & Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 12	Mar ' 11	Mar ' 10	Mar ' 09	Mar ' 08

Sources of funds

Owner's fund

Equity share capital

19.34

19.34

19.34

18.62

12.70

Share application money

257.33

-

-

10.02

8.72

Preference share capital

-

-

-

-

-

Reserves & surplus

-38.36

269.13

337.94

243.01

198.04

Loan funds

Secured loans

648.65

734.44

660.76

481.26

405.88

Unsecured loans

63.47

245.94

266.01

263.45

212.26

Total

950.44

1,268.85

1,284.05

1,016.35

837.59

Uses of funds

Fixed assets

Gross block

1,351.26

1,351.40

775.47

390.65

228.04

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

192.57

131.54

71.07

44.50

23.89

Net block

1,158.69

1,219.86

704.41

346.15

204.16

Capital work-in-progress

266.48

284.97

60.74

266.10

331.49

Investments

0.10

0.10

0.36

3.74

5.24

Net current assets

Current assets, loans & advances

103.38

274.55

723.99

518.28

358.52

Less : current liabilities & provisions

578.22

510.63

205.44

118.18

62.33

Total net current assets

-474.84

-236.07

518.55

400.09

296.19

Miscellaneous expenses not written

-

-

-

0.26

0.52

Total

950.44

1,268.85

1,284.05

1,016.35

837.59

Notes:

Book value of unquoted investments

0.10

0.10

0.36

3.74

5.24

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

30.44

38.36

23.97

Number of equity sharesoutstanding (Lacs)

193.42

193.42

193.42

186.15

127.01